Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Emisphere and Alchemia to develop oral formulation of fondaparinux anticoagulant

March 19, 2010

Vectura and Sandoz revise VR-315 agreement for U.S.

March 18, 2010

ALS Therapy Development Institute and Aestus to test potential ALS treatments

March 18, 2010

Tekmira and Pfizer collaborate on stable nucleic acid-lipid particle technology

March 17, 2010

Lilly to acquire worldwide license to Acrux's testosterone solution Axiron

March 17, 2010

Medicago and MOU partner to commercially develop influenza vaccines in Japan

March 17, 2010

LLS and Forma to develop new therapies for diffuse large B-cell lymphoma

March 17, 2010

Sigma-Aldrich to sell Pfizer's small-molecule compounds to researchers

March 16, 2010

Orexigen and Patheon enter into exclusive manufacturing agreement for Contrave

March 16, 2010

Eisai and Johns Hopkins to collaborate on development GCPII inhibitors

March 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...